Skip to content

Clinical trials

Completed Phase 2 Anemia, Sickle Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Phase: Phase 2 Status: Completed Clear all

104 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20021
20032
20046
20051
20063
20072
20082
20095
20105
20116
20123
20137
20144
20154
20166
20179
20186
20194
20202
20215
20225
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed104

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
National Heart, Lung, and Blood Institute (NHLBI)7
UCSF Benioff Children's Hospital Oakland6
Children's Hospital Medical Center, Cincinnati3
Emory University3
Johns Hopkins University3
Medical College of Wisconsin3
Prolong Pharmaceuticals3
St. Jude Children's Research Hospital3
Assistance Publique - Hôpitaux de Paris2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell104
Vaso-Occlusive Crises10
Anemia9
Hematologic Diseases7
Thalassemia7
Hemoglobinopathies6
Acute Chest Syndrome5
Genetic Diseases, Inborn5
beta-Thalassemia5
Albuminuria3

Trials

Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.

4 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.